ロード中...
Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells
BACKGROUND: Valosin containing protein (VCP) is a critical mediator of protein homeostasis and may represent a valuable therapeutic target for several forms of cancer. Overexpression of VCP occurs in many cancers, and often in a manner correlating with malignancy and poor outcome. Here, we analyzed...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479320/ https://ncbi.nlm.nih.gov/pubmed/26104798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1489-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|